• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION CONTEGRA; CONDUIT,VALVED,PULMONIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION CONTEGRA; CONDUIT,VALVED,PULMONIC Back to Search Results
Model Number PVC200
Device Problems Calcified (1077); Gradient Increase (1270)
Patient Problems Pulmonary Valve Stenosis (2024); Regurgitation, Valvular (2335)
Event Date 11/27/2015
Event Type  Injury  
Manufacturer Narrative
It was reported by the facility that the device would not be returned or made available for analysis.Without the return of the product, no definitive conclusion can be made regarding the clinical observation.(b)(4).
 
Event Description
Medtronic received information that one year post implant of this bioprosthetic valved conduit, an echocardiogram showed mild pulmonary stenosis, with a peak gradient of 17 mmhg, and mild-moderate narrowing of the distal conduit, proximal to the branch pulmonary arteries, with a peak gradient of 27 mmhg, mild pulmonary valve regurgitation, and dilated/hypokinetic right ventricular outflow tract (rvot) just proximal to the right ventricle to pulmonary artery (rv-pa) conduit.One year post-implant, the patient was admitted to the hospital for a febrile illness.At this time, a cardiac magnetic resonance imaging (mri) showed inflammation of the valved conduit itself with some surrounding soft tissue swelling.The rvot appeared significantly dilated, thin-walled and paradoxical to the level of this rv-pa conduit, consistent with an aneurysmally dilated rvot status post tetralogy of fallot and pulmonary atresia repair.Mild pulmonary regurgitation was observed.The wall of this valved conduit appeared relatively thickened and irregular with mild to moderate narrowing; mural thrombus could not definitively be excluded, but no obvious vegetation was seen in the conduit, or in the remainder of the heart, and the echocardiogram results appeared stable.Patient subsequently presented with a positive adenovirus and streptococcus pneumoniae bacteremia.A 10 day course of antibiotics was initiated.One year, six months post-implant, the patient presented with a significant increase in rv-pa conduit gradient, dilated and hypokinetic rvot just proximal to rv-pa conduit, moderate-severe narrowing of the distal conduit, mild pulmonary valve regurgitation.Two years, post-implant, the conduit was explanted and upsized, replaced with a 16 mm cryopreserved aortic homograft.Upon explant of this valved conduit, the physician reported that the pulmonary valve was slightly calcified and one of the leaflets appeared degenerated.A portion of this conduit was submitted to microbiology for gram staining and culturing.The microbiology lab reported no organisms were seen five days post-explant.No other adverse patient effects were reported.
 
Manufacturer Narrative
Conclusion: a review of the device history record showed that this device met all manufacturing specification for product released to distribution.No issues were noted that would have impacted this event.A true root cause to the reported clinical observations is not determined.Based on the above investigation, the endocarditis is unlikely to be attributed to the device and/or manufacturing process.Overall, a true root cause to the reported clinical observations is not determined.However, there is no indication that the reported clinical observations were related to the manufacture of the device.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONTEGRA
Type of Device
CONDUIT,VALVED,PULMONIC
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC STRUCTURAL HEART
8200 coral sea street ne
mounds view MN 55112
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key5367977
MDR Text Key36000098
Report Number2025587-2016-00060
Device Sequence Number1
Product Code MWH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
H020003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 03/02/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/26/2016
Device Model NumberPVC200
Device Catalogue Number200H12
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 01/13/2016
Initial Date FDA Received01/14/2016
Supplement Dates Manufacturer ReceivedNot provided
03/02/2016
Supplement Dates FDA Received03/08/2016
09/19/2017
Was Device Evaluated by Manufacturer? No
Date Device Manufactured07/23/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age00032 MO
Patient Weight11
-
-